- Global Pharma News & Resources

Diabetic Eye Disease Devices Global Market to Grow by 7.64% Annually Through 2029 -

DUBLIN--(BUSINESS WIRE)--The "Diabetic Eye Disease Devices Market Analysis, by Disease, by Devices, by End-User, and by Region - Global Forecast to 2029" report has been added to's offering.

The diabetic eye disease devices market size is estimated to be USD 1305.1 million in 2021 and is expected to witness a CAGR of 7.64% during the forecast period 2022-2029. The growing geriatric population, increasing the demand for diabetic eye disease devices, rising prevalence of diabetic eye diseases, eye injuries, hormone replacement therapy, hypertension, and obesity are factors contributing to the market growth. However, lack of qualified specialists with experience in ocular surgery and strict regulatory restrictions relating to the safety and efficacy of medical devices is expected to hinder the growth.


Disease (Revenue, USD Million)

  • Glaucoma
  • Diabetic Retinopathy
  • Cataract
  • Diabetic Macular Edema

Devices (Revenue, USD Million)

  • Ophthalmic Diagnostic & Monitoring Equipment
  • Surgery
  • Vision Care

End user (Revenue, USD Million)

  • Ophthalmic Clinics
  • Hospitals

By Region (Revenue, USD Million)

North America

  • U.S
  • Canada


  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Key Topics Covered:

1. Research Methodology

2. Introduction: Diabetic Eye Disease Devices

3. Executive Summary

4. Market Dynamics

5. Market Environment Analysis

6. COVID-19 Impact Analysis: Diabetic Eye Disease Devices Market

7. Market Analysis by Disease

8. Market Analysis by Devices

9. Market Analysis by End User

10. Regional Market Analysis

11. North America Diabetic Eye Disease Devices Market

12. Europe Diabetic Eye Disease Devices Market

13. Asia Pacific Diabetic Eye Disease Devices Market

14. Latin America Diabetic Eye Disease Devices Market

15. MEA Diabetic Eye Disease Devices Market

16. Competitor Analysis

17. Company Profiles

18. Conclusion & Recommendations

Companies Mentioned

  • Alcon
  • Bausch & Lomb Inc. (U.S.)
  • Pfizer (U.S.)
  • Alcon (U.S.)
  • Roche (Switzerland)
  • Santen (Japan)
  • Abbott Medical Optics (U.S.),Allergan (U.S.)
  • Nidek (Japan)
  • Carl Zeiss Meditec (Germany)
  • Merck (U.S.)
  • Essilor (France)
  • Johnson & Johnson (U.S.)
  • Topcon (Japan).

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 07-Oct-2022